Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/18/10/1673/308503/mdm269.pdf
Reference24 articles.
1. Patterns of cancer incidence, mortality, prevalence across five continents: Defining priorities to reduce cancer disparities in different geographical regions of the world;Kamangar;J Clin Oncol,2006
2. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data;Wagner;J Clin Oncol,2006
3. Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF);Mavroudis;Am J Clin Oncol,2000
4. Docetaxel (Taxotere) in advanced gastric cancer: Results of a phase II clinical trial—EORTC Early Clinical Trials Group;Sulkes;Br J Cancer,1994
5. Phase II trial of docetaxel (Taxotere) in patients with adenocarcinomas of the upper gastrointestinal tract previously untreated with cytotoxic chemotherapy: The Eastern Cooperative Oncology Group (ECOG) results of protocol E1293;Einzig;Med Oncol,1996
Cited by 114 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Efficacy and safety of docetaxel plus S-1-based therapy in gastric cancer: a quantitative evidence synthesis of randomized controlled trials;Frontiers in Pharmacology;2024-01-08
2. German, Austrian, and Swiss guidelines for systemic treatment of gastric cancer;Gastric Cancer;2023-10-17
3. Improving outcomes in patients with oesophageal cancer;Nature Reviews Clinical Oncology;2023-04-21
4. Implementation of Multimodality Therapy and Minimally Invasive Surgery: Short- and Long-term Outcomes of Gastric Cancer Surgery in Medium-Volume Center;Journal of Gastrointestinal Surgery;2022-08-24
5. Pre-operative Carboplatin/Paclitaxel Versus 5-Fluorouracil (5-FU)-based Chemoradiotherapy for Older Adults With Esophageal Cancer;Anticancer Research;2021-12-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3